EXACT Therapeutics AS Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2017
Net Income	-86.97	-52.33	-48.33	-40.1	-58.59	Upgrade
Depreciation & Amortization	3.68	2.43	2.09	1.94	1.83	Upgrade
Stock-Based Compensation	2.26	2.82	3.96	-0.4	4.16	Upgrade
Other Operating Activities	2.09	-0.52	0	-0.21	-0.52	Upgrade
Change in Accounts Receivable	12.69	-39.39	-1.32	-0.53	-1.62	Upgrade
Change in Accounts Payable	-0.75	6.53	-0.69	5.46	0.74	Upgrade
Change in Other Net Operating Assets	-	-0.08	-0	-	-1.11	Upgrade
Operating Cash Flow	-66.99	-80.55	-44.3	-33.85	-55.11	Upgrade
Capital Expenditures	-5.32	-1.51	-3.09	-0.25	-1.63	Upgrade
Investment in Securities	-	-	-	20.37	-	Upgrade
Other Investing Activities	2.62	0.92	0.95	0.48	0.62	Upgrade
Investing Cash Flow	-2.7	-0.58	-2.15	20.6	-1.01	Upgrade
Long-Term Debt Repaid	-0.76	-0.6	-0.58	-0.51	-0.44	Upgrade
Net Debt Issued (Repaid)	-0.76	-0.6	-0.58	-0.51	-0.44	Upgrade
Issuance of Common Stock	-	129.46	25	0.1	0.51	Upgrade
Other Financing Activities	-0.03	5.47	-1.25	-0.12	-0.12	Upgrade
Financing Cash Flow	-0.8	134.33	23.17	-0.53	-0.05	Upgrade
Foreign Exchange Rate Adjustments	-4.7	-0.1	0.32	0.26	-0.15	Upgrade
Miscellaneous Cash Flow Adjustments	-	-0	-	-	-	Upgrade
Net Cash Flow	-75.19	53.11	-22.96	-13.52	-56.31	Upgrade
Free Cash Flow	-72.31	-82.05	-47.39	-34.1	-56.74	Upgrade
Free Cash Flow Margin	-122558.79%	-	-1062987.39%	-7503.15%	-109106.39%	Upgrade
Free Cash Flow Per Share	-1.14	-2.37	-1.48	-1.14	-1.89	Upgrade
Cash Interest Paid	0.03	0.05	0.09	0.1	0.1	Upgrade
Levered Free Cash Flow	-55.69	-31.46	-29.35	-19.34	-34.63	Upgrade
Unlevered Free Cash Flow	-55.67	-31.43	-29.29	-19.27	-34.57	Upgrade
Change in Working Capital	11.94	-32.94	-2.02	4.92	-1.99	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.